How to judge a knee treatment claim

What to ask when a result sounds certain

First find the result: less soreness, longer walks, better bending, or easier sleep. The claim should say how many people improved and for how long.

Then find what happened with other care or saline in the knee. If both groups improved alike, that study didn't show added help from the procedure.

That is what was shown. Without a fair comparison, a claim only suggests the procedure helped; the exact cause remains unknown.

What to ask at the consultation

Bring notes about when the ache began, your drugs, and any earlier exam. Tell the clinician which daily task you most want to regain.

QC Kinetix in Chandler uses regenerative treatments, meaning staff make a knee procedure from your own blood. One is platelet-rich plasma (PRP); staff spin a blood sample to separate its layers, then put the platelet-rich portion into the joint.

Ask what your exam shows and what research found for similar knees. Your exact result isn't known.

What to use as your own measure

Pick one regular task, such as walking to the mailbox or standing from a chair. Record how far you go, your soreness, any swelling, and the next morning's stiffness.

A number matters only when it changes daily life. Easier steps and sounder sleep are clearer than a broad claim that a procedure worked.

When to stop reading and get care

Online words can't examine swelling, weakness, or buckling. Arrange a visit when soreness lasts or keeps returning after reasonable home care.

Get urgent help after a serious injury or when the knee heats up with fever. A cold foot also needs care now.

Sources

1. A Bayesian network meta-analysis restricted to LARGE randomized trials (>=100 patients per group) of 18 intra-articular interventions in knee and hip OA found treatment effects were larger in the 35 high-risk-of-bias trials than in the 22 low/unclear-risk trials. Excluding high-risk trials, triamcinolone had the highest probability of exceeding the minimal important difference at weeks 2 and 6; hyaluronic acid had NO effect on pain (SMD -0.04, 95% CrI -0.19 to 0.11) but higher odds of dropouts due to adverse events (OR 2.01) and of serious adverse events (OR 1.86) than placebo. Effects of 16 of the 18 interventions were smaller than the MID and most were consistent with placebo.

   da Costa BR, et al. — Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis.. Osteoarthritis and Cartilage, 2025. DOI: 10.1016/j.joca.2024.08.014.

2. An individual-participant-data meta-analysis of 621 placebo participants across 10 intra-articular injection trials found placebo response (>=20% pain reduction) was itself predictable: use of local anaesthetic and ultrasound guidance were associated with REDUCED odds of short-term placebo response, and longer trial duration with increased odds at midterm. Any single-arm 'our patients got better' claim about an injection is therefore uninterpretable.

   Zou K, et al. — Predictors of Placebo Response to Local (Intra-Articular) Therapy In Osteoarthritis: An Individual Participant Data Meta-Analysis.. Arthritis Care & Research, 2024. DOI: 10.1002/acr.25212.

3. The RESTORE trial randomized 288 adults aged 50+ with symptomatic mild-to-moderate medial knee OA to three weekly leukocyte-poor PRP injections or saline placebo. At 12 months, pain change was -2.1 vs -1.8 points (difference -0.4; 95% CI -0.9 to 0.2; P=.17) and medial tibial cartilage volume change was -1.4% vs -1.2% (P=.81). 29 of 31 prespecified secondary outcomes showed no significant between-group difference. The authors concluded the findings 'do not support use of PRP for the management of knee OA.'

   Bennell KL, Paterson KL, Metcalf BR, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

4. In a placebo-surgery-controlled trial of 180 patients with knee OA, neither arthroscopic debridement nor arthroscopic lavage outperformed placebo surgery at ANY time point over 24 months on any of five self-reported pain/function scales or an objective walking and stair-climbing test.

   Moseley JB, O'Malley K, Petersen NJ, et al. — A controlled trial of arthroscopic surgery for osteoarthritis of the knee.. New England Journal of Medicine, 2002. DOI: 10.1056/NEJMoa013259.

5. In a double-blind, sham-controlled trial of 146 patients aged 35-65 with a degenerative medial meniscus tear and NO knee osteoarthritis, arthroscopic partial meniscectomy produced no significant benefit over sham surgery on any primary outcome at 12 months (Lysholm 21.7 vs 23.3 points; WOMET 24.6 vs 27.1; pain after exercise 3.1 vs 3.3).

   Sihvonen R, Paavola M, Malmivaara A, et al. — Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear.. New England Journal of Medicine, 2013. DOI: 10.1056/NEJMoa1305189.

6. A 2026 network meta-analysis of 21 RCTs (2,254 patients) found both leukocyte-poor and leukocyte-rich PRP significantly improved 6-12 month WOMAC function versus placebo (MD -10.54 and -13.20 respectively) and both were superior to hyaluronic acid, with leukocyte-poor PRP ranked first (P-score 0.96) — a materially more favourable read of PRP than the RESTORE trial, which is why this corpus presents both.

   Journal of Orthopaedic Surgery and Research authors — Leukocyte-rich versus leukocyte-poor platelet-rich plasma and hyaluronic acid for knee osteoarthritis: a systematic review and network meta-analysis.. Journal of Orthopaedic Surgery and Research, 2026. DOI: 10.1186/s13018-026-06689-4.

7. A safety review of intra-articular PRP in knee OA found significantly higher rates of mild knee pain and swelling than hyaluronic acid (p<0.001), driven specifically by leukocyte-RICH formulations; leukocyte-poor PRP showed a safety profile similar to HA. No severe adverse events were reported in any group.

   PM&R authors — Assessment of adverse events and safety associated with intra-articular platelet-rich plasma injections compared with hyaluronic acid and saline in knee osteoarthritis.. PM&R, 2026. DOI: 10.1002/pmrj.70141.